封面
市場調查報告書
商品編碼
1528015

全球神經刺激設備市場

Neurostimulation Devices

出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 163 Pages | 商品交期: 最快1-2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年,全球神經刺激設備市場預計將達到 132 億美元

全球神經刺激設備市場預計 2023 年為 80 億美元,預計到 2030 年將達到 132 億美元,2023 年至 2030 年複合年成長率為 7.3%。脊髓刺激設備是本報告分析的細分市場之一,預計複合年成長率為 8.3%,到分析期結束時將達到 48 億美元。在分析期間,深部腦部刺激器細分市場的複合年成長率預計為 7.5%。

美國市場預計將成長22億美元,中國複合年成長率為11.9%

預計 2023 年美國神經刺激設備市場規模將達 22 億美元。中國作為世界第二大經濟體,預計2030年市場規模將達31億美元,2023-2030年分析期間複合年成長率為11.9%。其他值得注意的區域市場包括日本和加拿大,在分析期間預計複合年成長率分別為 2.7% 和 7.6%。在歐洲,德國的複合年成長率預計為 4.2%。

全球神經刺激設備市場 - 主要趨勢與促進因素總結

什麼是神經刺激設備以及它們為何重要?

神經刺激設備是一種先進的醫療技術,旨在透過電刺激改變神經系統的活動。這些設備用於治療各種神經系統疾病和慢性疼痛,為傳統治療失敗時提供了一種治療選擇。常見用途包括治療慢性疼痛的脊髓刺激、治療帕金森氏症等運動障礙的腦深部刺激以及治療癲癇和憂鬱症的迷走神經刺激。神經刺激設備的價值在於它們能夠以微創方式提供標靶治療,緩解患者的衰弱症狀並改善生活品質。這些設備的準確性和有效性使其成為管理複雜神經系統疾病套件的重要組成部分。

科技進步如何改進神經刺激設備?

技術進步不斷改進神經刺激設備的功能和應用。關鍵創新之一是閉合迴路系統的開發,該系統允許根據患者的生理反應即時自動調整刺激參數。這可以讓您獲得最佳的治療效果,同時最大限度地減少副作用。電池技術的進步也促進了更耐用、更有效率的設備的開發,減少了更換電池的外科手術頻率。此外,無線技術的整合允許遠端監控和調整,為患者和醫療保健提供者增加便利性。微電子和生物材料研究正在開發更小、更隱密的植入,這些植入物侵入性更小,對患者來說更舒適。這些技術進步不僅提高了神經刺激設備的功能和易用性,而且還擴展了其在治療更廣泛疾病方面的潛在應用。

神經刺激市場有哪些新趨勢與創新?

神經刺激市場正在見證一些將塑造其未來的新趨勢和創新。一個重要的趨勢是對個人化醫療的日益關注,其中神經刺激療法根據個別患者獨特的神經學特徵根據其特定需求進行客製化。另一個重要的發展是神經刺激在非傳統領域的廣泛應用,例如憂鬱症和焦慮症等精神疾病以及阿茲海默症神經退化性疾病的認知增強。人們對非侵入性神經刺激設備也產生了濃厚的興趣,例如經顱磁刺激(TMS)和經皮神經電刺激(TENS),這些設備無需手術植入即可提供治療效果。此外,使用人工智慧(AI)和機器學習演算法的神經刺激設備的進一步研究預計將進一步完善和增強治療通訊協定,提供更有效和個人化的治療方案。這些趨勢凸顯了神經刺激市場的動態和創新本質,其驅動力是不斷追求改善患者治療效果和擴大治療可能性。

推動神經刺激設備市場成長的因素有哪些?

神經刺激設備市場的成長受到多種因素的推動。首先,慢性疼痛和神經病變的盛行率不斷增加是重要的促進因素。這是因為這些疾病通常需要長期治療,而神經刺激設備可以提供這種治療。閉合迴路系統和無線功能的開發等技術進步透過改善設備功能和患者依從性來推動市場成長。神經刺激在精神疾病和認知障礙治療中的廣泛應用正在創造新的市場機會。此外,向個人化醫療的轉變,即根據患者個別需求量身定做治療方法,正在推動對先進神經刺激解決方案的需求。監管部門的核准和優惠的報銷政策也使這些先進的治療方法更容易獲得,從而推動了市場的擴張。此外,世界人口老化使得更容易罹患神經系統疾病和慢性疼痛,這也促使神經刺激設備的採用越來越多。最後,市場成長是由於醫療保健專業人員和患者對神經刺激作為一種可行的治療選擇的認知和接受程度不斷提高而推動的,這使得神經刺激設備發揮越來越重要的作用。

受訪企業範例(32家知名企業)

  • Boston Scientific Corporation
  • LivaNova PLC
  • Medtronic, Inc.
  • NeuroPace, Inc.
  • NeuroSigma, Inc.

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 比賽

簡介目錄
Product Code: MCP-1227

Global Neurostimulation Devices Market to Reach US$13.2 Billion by 2030

The global market for Neurostimulation Devices estimated at US$8.0 Billion in the year 2023, is expected to reach US$13.2 Billion by 2030, growing at a CAGR of 7.3% over the analysis period 2023-2030. Spinal Cord Stimulation Devices, one of the segments analyzed in the report, is expected to record a 8.3% CAGR and reach US$4.8 Billion by the end of the analysis period. Growth in the Deep Brain Stimulation Devices segment is estimated at 7.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.2 Billion While China is Forecast to Grow at 11.9% CAGR

The Neurostimulation Devices market in the U.S. is estimated at US$2.2 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$3.1 Billion by the year 2030 trailing a CAGR of 11.9% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.7% and 7.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.2% CAGR.

Global Neurostimulation Devices Market - Key Trends and Drivers Summarized

What Are Neurostimulation Devices and Why Are They Important?

Neurostimulation devices are sophisticated medical technologies designed to alter nervous system activity through electrical stimulation. These devices are used to treat a variety of neurological disorders and chronic pain conditions, offering a therapeutic option where traditional treatments may have failed. Common applications include spinal cord stimulation for chronic pain management, deep brain stimulation for movement disorders like Parkinson’s disease, and vagus nerve stimulation for epilepsy and depression. The significance of neurostimulation devices lies in their ability to provide targeted therapy with minimal invasiveness, offering patients relief from debilitating symptoms and improving their quality of life. The precision and effectiveness of these devices have made them a crucial component in the toolkit for managing complex neurological conditions.

How Are Technological Advancements Enhancing Neurostimulation Devices?

Technological advancements are continuously enhancing the capabilities and applications of neurostimulation devices. One of the major innovations is the development of closed-loop systems, which can automatically adjust stimulation parameters in real-time based on the patient's physiological responses. This ensures optimal therapeutic outcomes while minimizing side effects. Advances in battery technology have also led to longer-lasting and more efficient devices, reducing the frequency of surgical interventions for battery replacements. Furthermore, the integration of wireless technology allows for remote monitoring and adjustments, providing greater convenience for both patients and healthcare providers. Research into microelectronics and biocompatible materials has resulted in smaller, more discreet implants that are less invasive and more comfortable for patients. These technological strides not only improve the functionality and usability of neurostimulation devices but also expand their potential applications in treating a broader range of conditions.

What Are the Emerging Trends and Innovations in the Neurostimulation Market?

The neurostimulation market is witnessing several emerging trends and innovations that are set to shape its future. One significant trend is the increasing focus on personalized medicine, where neurostimulation therapies are tailored to the specific needs of individual patients based on their unique neurological profiles. Another important development is the growing application of neurostimulation in non-traditional areas such as psychiatric disorders, including depression and anxiety, and even for cognitive enhancement in neurodegenerative diseases like Alzheimer's. The market is also seeing a surge in interest for non-invasive neurostimulation devices, such as transcranial magnetic stimulation (TMS) and transcutaneous electrical nerve stimulation (TENS), which offer therapeutic benefits without the need for surgical implantation. Additionally, ongoing research into the use of artificial intelligence (AI) and machine learning algorithms in neurostimulation devices promises to further refine and enhance treatment protocols, providing more effective and individualized therapy options. These trends highlight the dynamic and innovative nature of the neurostimulation market, driven by the constant quest to improve patient outcomes and expand therapeutic possibilities.

What Factors Are Driving the Growth in the Neurostimulation Devices Market?

The growth in the neurostimulation devices market is driven by several factors. Firstly, the increasing prevalence of chronic pain and neurological disorders is a significant driver, as these conditions often require long-term management that neurostimulation devices can provide. Technological advancements, such as the development of closed-loop systems and wireless capabilities, are propelling market growth by enhancing device functionality and patient compliance. The expanding applications of neurostimulation in treating psychiatric disorders and cognitive impairments are opening new market opportunities. Additionally, the shift towards personalized medicine, where treatments are tailored to individual patient needs, is driving demand for sophisticated neurostimulation solutions. Regulatory approvals and favorable reimbursement policies are also facilitating market expansion by making these advanced therapies more accessible. Furthermore, the aging global population, which is more susceptible to neurological and chronic pain conditions, is contributing to the increased adoption of neurostimulation devices. Finally, growing awareness and acceptance of neurostimulation as a viable therapeutic option among both healthcare providers and patients are fueling market growth, ensuring these devices play an increasingly vital role in managing complex medical conditions.

Select Competitors (Total 32 Featured) -

  • Boston Scientific Corporation
  • LivaNova PLC
  • Medtronic, Inc.
  • NeuroPace, Inc.
  • NeuroSigma, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Global Economic Update
    • Neurostimulation Devices - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Prevalence of Neurological Disorders Spurs Growth in Neurostimulation Devices
    • Technological Advancements in Closed-Loop Systems Propel Market Expansion
    • Personalized Medicine Expands Addressable Market Opportunity for Tailored Neurostimulation Therapies
    • Non-Invasive Neurostimulation Devices Here's How They Drive Adoption
    • Integration of Wireless Technology Strengthens Business Case for Remote Monitoring and Adjustments
    • Growing Applications in Psychiatric Disorders Generates Demand for Advanced Neurostimulation Solutions
    • Aging Global Population Throws the Spotlight on Increased Neurostimulation Device Adoption
    • Artificial Intelligence and Machine Learning Accelerates Demand for Intelligent Neurostimulation Devices
    • Increasing Use in Cognitive Enhancement for Neurodegenerative Diseases Expands Market Reach
    • Rising Awareness and Acceptance Drives Adoption Among Healthcare Providers and Patients
    • Advances in Microelectronics and Biocompatible Materials Sustain Growth in Device Miniaturization
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Neurostimulation Devices Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Neurostimulation Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Neurostimulation Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Neurostimulation Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Spinal Cord Stimulation Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Spinal Cord Stimulation Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Spinal Cord Stimulation Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Deep Brain Stimulation Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Deep Brain Stimulation Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Deep Brain Stimulation Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Sacral Nerve Stimulation Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Sacral Nerve Stimulation Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Sacral Nerve Stimulation Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Vagus Nerve Stimulation Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Vagus Nerve Stimulation Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Vagus Nerve Stimulation Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Gastric Electric Stimulation Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Gastric Electric Stimulation Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Gastric Electric Stimulation Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Other Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Pain Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Pain Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Pain Management by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Epilepsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Epilepsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: World 16-Year Perspective for Epilepsy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Parkinson's by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Parkinson's by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: World 16-Year Perspective for Parkinson's by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Urinary & Fecal Incontinence by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Urinary & Fecal Incontinence by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: World 16-Year Perspective for Urinary & Fecal Incontinence by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Alzheimer's by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Alzheimer's by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: World 16-Year Perspective for Alzheimer's by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Neurostimulation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 41: USA Recent Past, Current & Future Analysis for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: USA 16-Year Perspective for Neurostimulation Devices by Product - Percentage Breakdown of Value Sales for Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products for the Years 2014, 2024 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: USA 16-Year Perspective for Neurostimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Canada 16-Year Perspective for Neurostimulation Devices by Product - Percentage Breakdown of Value Sales for Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products for the Years 2014, 2024 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Canada 16-Year Perspective for Neurostimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications for the Years 2014, 2024 & 2030
  • JAPAN
    • Neurostimulation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Japan 16-Year Perspective for Neurostimulation Devices by Product - Percentage Breakdown of Value Sales for Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products for the Years 2014, 2024 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Japan 16-Year Perspective for Neurostimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications for the Years 2014, 2024 & 2030
  • CHINA
    • Neurostimulation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 59: China Recent Past, Current & Future Analysis for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: China 16-Year Perspective for Neurostimulation Devices by Product - Percentage Breakdown of Value Sales for Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products for the Years 2014, 2024 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: China 16-Year Perspective for Neurostimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications for the Years 2014, 2024 & 2030
  • EUROPE
    • Neurostimulation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Neurostimulation Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Neurostimulation Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Europe 16-Year Perspective for Neurostimulation Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Europe 16-Year Perspective for Neurostimulation Devices by Product - Percentage Breakdown of Value Sales for Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products for the Years 2014, 2024 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Europe 16-Year Perspective for Neurostimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications for the Years 2014, 2024 & 2030
  • FRANCE
    • Neurostimulation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 74: France Recent Past, Current & Future Analysis for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: France Historic Review for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: France 16-Year Perspective for Neurostimulation Devices by Product - Percentage Breakdown of Value Sales for Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products for the Years 2014, 2024 & 2030
    • TABLE 77: France Recent Past, Current & Future Analysis for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: France Historic Review for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: France 16-Year Perspective for Neurostimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications for the Years 2014, 2024 & 2030
  • GERMANY
    • Neurostimulation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 80: Germany Recent Past, Current & Future Analysis for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Germany Historic Review for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Germany 16-Year Perspective for Neurostimulation Devices by Product - Percentage Breakdown of Value Sales for Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products for the Years 2014, 2024 & 2030
    • TABLE 83: Germany Recent Past, Current & Future Analysis for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Germany Historic Review for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Germany 16-Year Perspective for Neurostimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 86: Italy Recent Past, Current & Future Analysis for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Italy Historic Review for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Italy 16-Year Perspective for Neurostimulation Devices by Product - Percentage Breakdown of Value Sales for Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products for the Years 2014, 2024 & 2030
    • TABLE 89: Italy Recent Past, Current & Future Analysis for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Italy Historic Review for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Italy 16-Year Perspective for Neurostimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Neurostimulation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 92: UK Recent Past, Current & Future Analysis for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: UK Historic Review for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: UK 16-Year Perspective for Neurostimulation Devices by Product - Percentage Breakdown of Value Sales for Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products for the Years 2014, 2024 & 2030
    • TABLE 95: UK Recent Past, Current & Future Analysis for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: UK Historic Review for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: UK 16-Year Perspective for Neurostimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 98: Spain Recent Past, Current & Future Analysis for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Spain Historic Review for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Spain 16-Year Perspective for Neurostimulation Devices by Product - Percentage Breakdown of Value Sales for Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products for the Years 2014, 2024 & 2030
    • TABLE 101: Spain Recent Past, Current & Future Analysis for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Spain Historic Review for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Spain 16-Year Perspective for Neurostimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 104: Russia Recent Past, Current & Future Analysis for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Russia Historic Review for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Russia 16-Year Perspective for Neurostimulation Devices by Product - Percentage Breakdown of Value Sales for Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products for the Years 2014, 2024 & 2030
    • TABLE 107: Russia Recent Past, Current & Future Analysis for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Russia Historic Review for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Russia 16-Year Perspective for Neurostimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 110: Rest of Europe Recent Past, Current & Future Analysis for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Rest of Europe Historic Review for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: Rest of Europe 16-Year Perspective for Neurostimulation Devices by Product - Percentage Breakdown of Value Sales for Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products for the Years 2014, 2024 & 2030
    • TABLE 113: Rest of Europe Recent Past, Current & Future Analysis for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Rest of Europe Historic Review for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: Rest of Europe 16-Year Perspective for Neurostimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Neurostimulation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 116: Asia-Pacific Recent Past, Current & Future Analysis for Neurostimulation Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 117: Asia-Pacific Historic Review for Neurostimulation Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: Asia-Pacific 16-Year Perspective for Neurostimulation Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 119: Asia-Pacific Recent Past, Current & Future Analysis for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: Asia-Pacific Historic Review for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: Asia-Pacific 16-Year Perspective for Neurostimulation Devices by Product - Percentage Breakdown of Value Sales for Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products for the Years 2014, 2024 & 2030
    • TABLE 122: Asia-Pacific Recent Past, Current & Future Analysis for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Asia-Pacific Historic Review for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: Asia-Pacific 16-Year Perspective for Neurostimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Neurostimulation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 125: Australia Recent Past, Current & Future Analysis for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Australia Historic Review for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: Australia 16-Year Perspective for Neurostimulation Devices by Product - Percentage Breakdown of Value Sales for Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products for the Years 2014, 2024 & 2030
    • TABLE 128: Australia Recent Past, Current & Future Analysis for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Australia Historic Review for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: Australia 16-Year Perspective for Neurostimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications for the Years 2014, 2024 & 2030
  • INDIA
    • Neurostimulation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 131: India Recent Past, Current & Future Analysis for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 132: India Historic Review for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: India 16-Year Perspective for Neurostimulation Devices by Product - Percentage Breakdown of Value Sales for Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products for the Years 2014, 2024 & 2030
    • TABLE 134: India Recent Past, Current & Future Analysis for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: India Historic Review for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: India 16-Year Perspective for Neurostimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 137: South Korea Recent Past, Current & Future Analysis for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 138: South Korea Historic Review for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: South Korea 16-Year Perspective for Neurostimulation Devices by Product - Percentage Breakdown of Value Sales for Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products for the Years 2014, 2024 & 2030
    • TABLE 140: South Korea Recent Past, Current & Future Analysis for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 141: South Korea Historic Review for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: South Korea 16-Year Perspective for Neurostimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 143: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Rest of Asia-Pacific Historic Review for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: Rest of Asia-Pacific 16-Year Perspective for Neurostimulation Devices by Product - Percentage Breakdown of Value Sales for Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products for the Years 2014, 2024 & 2030
    • TABLE 146: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Rest of Asia-Pacific Historic Review for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 148: Rest of Asia-Pacific 16-Year Perspective for Neurostimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Neurostimulation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 149: Latin America Recent Past, Current & Future Analysis for Neurostimulation Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 150: Latin America Historic Review for Neurostimulation Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 151: Latin America 16-Year Perspective for Neurostimulation Devices by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 152: Latin America Recent Past, Current & Future Analysis for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Latin America Historic Review for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 154: Latin America 16-Year Perspective for Neurostimulation Devices by Product - Percentage Breakdown of Value Sales for Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products for the Years 2014, 2024 & 2030
    • TABLE 155: Latin America Recent Past, Current & Future Analysis for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Latin America Historic Review for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 157: Latin America 16-Year Perspective for Neurostimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 158: Argentina Recent Past, Current & Future Analysis for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Argentina Historic Review for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 160: Argentina 16-Year Perspective for Neurostimulation Devices by Product - Percentage Breakdown of Value Sales for Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products for the Years 2014, 2024 & 2030
    • TABLE 161: Argentina Recent Past, Current & Future Analysis for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Argentina Historic Review for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 163: Argentina 16-Year Perspective for Neurostimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 164: Brazil Recent Past, Current & Future Analysis for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Brazil Historic Review for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 166: Brazil 16-Year Perspective for Neurostimulation Devices by Product - Percentage Breakdown of Value Sales for Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products for the Years 2014, 2024 & 2030
    • TABLE 167: Brazil Recent Past, Current & Future Analysis for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Brazil Historic Review for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 169: Brazil 16-Year Perspective for Neurostimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 170: Mexico Recent Past, Current & Future Analysis for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Mexico Historic Review for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 172: Mexico 16-Year Perspective for Neurostimulation Devices by Product - Percentage Breakdown of Value Sales for Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products for the Years 2014, 2024 & 2030
    • TABLE 173: Mexico Recent Past, Current & Future Analysis for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Mexico Historic Review for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 175: Mexico 16-Year Perspective for Neurostimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 176: Rest of Latin America Recent Past, Current & Future Analysis for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Rest of Latin America Historic Review for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 178: Rest of Latin America 16-Year Perspective for Neurostimulation Devices by Product - Percentage Breakdown of Value Sales for Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products for the Years 2014, 2024 & 2030
    • TABLE 179: Rest of Latin America Recent Past, Current & Future Analysis for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Rest of Latin America Historic Review for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 181: Rest of Latin America 16-Year Perspective for Neurostimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Neurostimulation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 182: Middle East Recent Past, Current & Future Analysis for Neurostimulation Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 183: Middle East Historic Review for Neurostimulation Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 184: Middle East 16-Year Perspective for Neurostimulation Devices by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 185: Middle East Recent Past, Current & Future Analysis for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Middle East Historic Review for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 187: Middle East 16-Year Perspective for Neurostimulation Devices by Product - Percentage Breakdown of Value Sales for Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products for the Years 2014, 2024 & 2030
    • TABLE 188: Middle East Recent Past, Current & Future Analysis for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Middle East Historic Review for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 190: Middle East 16-Year Perspective for Neurostimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 191: Iran Recent Past, Current & Future Analysis for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 192: Iran Historic Review for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 193: Iran 16-Year Perspective for Neurostimulation Devices by Product - Percentage Breakdown of Value Sales for Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products for the Years 2014, 2024 & 2030
    • TABLE 194: Iran Recent Past, Current & Future Analysis for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 195: Iran Historic Review for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 196: Iran 16-Year Perspective for Neurostimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 197: Israel Recent Past, Current & Future Analysis for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Israel Historic Review for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 199: Israel 16-Year Perspective for Neurostimulation Devices by Product - Percentage Breakdown of Value Sales for Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products for the Years 2014, 2024 & 2030
    • TABLE 200: Israel Recent Past, Current & Future Analysis for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Israel Historic Review for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 202: Israel 16-Year Perspective for Neurostimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 203: Saudi Arabia Recent Past, Current & Future Analysis for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Saudi Arabia Historic Review for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 205: Saudi Arabia 16-Year Perspective for Neurostimulation Devices by Product - Percentage Breakdown of Value Sales for Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products for the Years 2014, 2024 & 2030
    • TABLE 206: Saudi Arabia Recent Past, Current & Future Analysis for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Saudi Arabia Historic Review for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 208: Saudi Arabia 16-Year Perspective for Neurostimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 209: UAE Recent Past, Current & Future Analysis for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 210: UAE Historic Review for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 211: UAE 16-Year Perspective for Neurostimulation Devices by Product - Percentage Breakdown of Value Sales for Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products for the Years 2014, 2024 & 2030
    • TABLE 212: UAE Recent Past, Current & Future Analysis for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 213: UAE Historic Review for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 214: UAE 16-Year Perspective for Neurostimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 215: Rest of Middle East Recent Past, Current & Future Analysis for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 216: Rest of Middle East Historic Review for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 217: Rest of Middle East 16-Year Perspective for Neurostimulation Devices by Product - Percentage Breakdown of Value Sales for Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products for the Years 2014, 2024 & 2030
    • TABLE 218: Rest of Middle East Recent Past, Current & Future Analysis for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 219: Rest of Middle East Historic Review for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 220: Rest of Middle East 16-Year Perspective for Neurostimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications for the Years 2014, 2024 & 2030
  • AFRICA
    • Neurostimulation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 221: Africa Recent Past, Current & Future Analysis for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 222: Africa Historic Review for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 223: Africa 16-Year Perspective for Neurostimulation Devices by Product - Percentage Breakdown of Value Sales for Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products for the Years 2014, 2024 & 2030
    • TABLE 224: Africa Recent Past, Current & Future Analysis for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 225: Africa Historic Review for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 226: Africa 16-Year Perspective for Neurostimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications for the Years 2014, 2024 & 2030

IV. COMPETITION